Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-50,400
Closed -$166K 2243
2025
Q3
$166K Buy
50,400
+3,200
+7% +$9.04K ﹤0.01% 1632
2025
Q2
$67K Hold
47,200
﹤0.01% 1970
2025
Q1
$70.3K Hold
47,200
﹤0.01% 1729
2024
Q4
$52.9K Hold
47,200
﹤0.01% 1724
2024
Q3
$44.7K Hold
47,200
﹤0.01% 1818
2024
Q2
$74.6K Hold
47,200
﹤0.01% 1743
2024
Q1
$68K Sell
47,200
-3,000
-6% -$4.31K ﹤0.01% 1735
2023
Q4
$67K Hold
50,200
﹤0.01% 1743
2023
Q3
$71K Hold
50,200
﹤0.01% 1760
2023
Q2
$57K Hold
50,200
﹤0.01% 1796
2023
Q1
$53K Hold
50,200
﹤0.01% 1778
2022
Q4
$76K Buy
+50,200
New +$86.3K ﹤0.01% 1760
2013
Q4
Sell
-5,441
Closed -$123K 1797
2013
Q3
$123K Buy
+5,441
New +$126K ﹤0.01% 1602

Other funds holding PGEN

STRS Ohio's PGEN Position: Q4 2025 in Review

STRS Ohio sold out of Precigen (PGEN) in Q4 2025, closing a stake of 50,400 shares — an estimated $166K sold.

STRS Ohio first reported a position in PGEN in Q3 2013 and held it in 13 quarters. The position peaked at $166K in Q3 2025. 179 funds tracked by Wall St. Rank hold PGEN as of Q4 2025.

  • STRS Ohio reported no remaining Precigen position as of Q4 2025 after selling out during the quarter.
  • STRS Ohio sold 50,400 Precigen shares in Q4 2025, an estimated $166K.
  • STRS Ohio first reported a position in Precigen in Q3 2013 and held it in 13 quarters.
  • STRS Ohio's Precigen position peaked at $166K in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Precigen as of Q4 2025.

Based on STRS Ohio's 13F filing for Q4 2025, filed 2 Feb 2026.